|
|
| Neurologie > Etude de marché sectorielle |
|
|
|
|
€ 170,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
29 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
New Drugs in Development for Alzheimer's Disease Indications Addressed
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
US Antidepressants 2004
12 pages | Décembre 2004 |
Snapdata's US Antidepressants 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US antidepressant market, and |
240,00 €
|
| |
| |
Stakeholder Insight: Cognitive Impairment in Schizoaffective Disorder - Inevitable or Treatable?
259 pages | Octobre 2005 |
IntroductionCognitive impairment is regarded as a core deficit of schizophrenia; the primary unmet need is the availability of an effective drug for the treatment of cognitive impairment in schizophre |
12 920,00 €
|
| |
| |
MarketWatch: CNS
25 pages | Février 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
Zoloft Annual Sales, 2000-2006
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
New Drugs in Development for Attention-Deficit/Hyperactivity Disorder
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Antidepressants
408 pages | Février 2006 |
This report analyzes the worldwide markets for Antidepressants in Millions of US$.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Ja |
3 091,00 €
|
| |
| |
The CNS Market Outlook to 2010
188 pages | Octobre 2005 |
CNS disorders contribute to as much as 35% of the disease burden in the seven major pharmaceutical markets (US, Japan, France, Germany, Italy, Spain and UK) as measured in terms of daily-adjusted life |
2 443,75 €
|
| |
| |
05-070: The Neuroscience Perspective: Opportunities for Market Entry & Expansion
138 pages | Octobre 2005 |
This report provides suppliers with critical information regarding neuroscientists’ preferred techniques and instrumentation in four strategic areas: nucleic acids, proteins, cells and imaging |
2 400,00 €
|
| |
| |
Schizophrenia Facts
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the
CNS industry.
|
|
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the
CNS industry.
|
|
|
PPLSEN
|
|
|
|
|
